Spontaneous rupture of splenic angiosarcoma: a case report of chemotherapeutic approach and review of the literature.
Angiosarcoma of the spleen is a rare disease, and the prognosis of this disease is extremely unfavorable. We herein review the case of a 45-year-old Japanese woman, who received a combined chemotherapy with cyclophosphamide, Adriamycin, vincristine, and prednisone after splenectomy and experienced a good response. The various types of chemotherapy for this disease are also discussed with references to the above case because no effective chemotherapeutic protocol for angiosarcomas has yet to be established.
Miyata
T
T
Itoda Hospital, Itoda, Fukuoka, Japan.
Fujimoto
Y
Y
Fukushima
M
M
Torisu
M
M
Tanaka
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006394:Hemangiosarcoma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011182:Postoperative Care; D011241:Prednisone / Q000008:administration & dosage; D012422:Rupture, Spontaneous; D013156:Splenectomy; D013160:Splenic Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013161:Splenic Rupture / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology / Q000601:surgery; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone